Cervarix approved in Japan; Cardium prices $6M RDO;

> GlaxoSmithKline has won Japanese approval for its HPV vaccine Cervarix. Report

> Cardium Therapeutics has announced a $6 million registered direct offering. Report

Pharma News

> The pharma sales rep bloodbath continues. Bristol-Myers Squibb has axed one-fourth of the sales force for its antipsychotic drug Abilify. Report

> The government crusade against "pay-for-delay" patent settlements continues--this time, in the U.S. Report

> Another day, another third-quarter financial cascade. Today, the numbers come from Cubist Pharmaceuticals and OSI Pharmaceuticals. And we get a preview of the big earnings announcements coming up from Pfizer and Merck. Earnings report

And Finally... As if to underscore the difficulty of keeping online-marketing rules current, Google has launched Sidewiki. It's a toolbar extension that adds a "sidebar" where people can comment on any and every website, plus respond to other comments. As Advertising Age notes, it's a potential thicket of trouble for pharma. Report

Suggested Articles

Half of patients in an early trial of Allogene's off-the-shelf CAR-T cells for lymphoma who received a higher dose of its antibody ALLO-647 responded.

Takeda is tossing out a Shire pipeline med after it couldn't find a buyer.

Ipsen's new hire arrives at a company reeling from a torrent six months that have crushed hopes for its $1 billion bet on a rare disease drug.